Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroscopy | 63 | 2018 | 198 | 18.010 |
Why?
|
Rotator Cuff | 22 | 2018 | 66 | 5.510 |
Why?
|
Periodicals as Topic | 17 | 2015 | 87 | 4.950 |
Why?
|
Anterior Cruciate Ligament | 18 | 2013 | 41 | 4.580 |
Why?
|
Shoulder Joint | 19 | 2018 | 122 | 4.530 |
Why?
|
Publishing | 14 | 2015 | 51 | 3.230 |
Why?
|
Knee Joint | 14 | 2019 | 125 | 3.060 |
Why?
|
Osteoarthritis, Knee | 9 | 2023 | 78 | 2.650 |
Why?
|
Arthroplasty, Replacement, Knee | 8 | 2018 | 83 | 2.360 |
Why?
|
Joint Diseases | 6 | 2014 | 33 | 2.220 |
Why?
|
Humans | 117 | 2023 | 28304 | 2.170 |
Why?
|
Orthopedics | 14 | 2022 | 93 | 2.150 |
Why?
|
Evidence-Based Medicine | 10 | 2014 | 196 | 2.130 |
Why?
|
Biomedical Research | 7 | 2013 | 144 | 1.900 |
Why?
|
Practice Guidelines as Topic | 5 | 2014 | 369 | 1.860 |
Why?
|
Hip Joint | 6 | 2010 | 56 | 1.720 |
Why?
|
Cartilage, Articular | 7 | 2023 | 68 | 1.600 |
Why?
|
Reconstructive Surgical Procedures | 8 | 2011 | 181 | 1.460 |
Why?
|
Knee Injuries | 5 | 2013 | 37 | 1.320 |
Why?
|
Orthopedic Procedures | 5 | 2012 | 89 | 1.220 |
Why?
|
Arm Injuries | 3 | 2013 | 20 | 1.220 |
Why?
|
Tendons | 6 | 2016 | 57 | 1.170 |
Why?
|
Menisci, Tibial | 5 | 2013 | 24 | 1.080 |
Why?
|
Tendon Injuries | 4 | 2013 | 36 | 1.060 |
Why?
|
Elbow Joint | 3 | 2017 | 53 | 1.040 |
Why?
|
Platelet-Rich Plasma | 4 | 2013 | 9 | 1.030 |
Why?
|
Research Design | 4 | 2012 | 271 | 1.000 |
Why?
|
Achilles Tendon | 3 | 2012 | 21 | 0.980 |
Why?
|
Conflict of Interest | 8 | 2011 | 39 | 0.930 |
Why?
|
Sports Medicine | 2 | 2014 | 21 | 0.930 |
Why?
|
Cartilage | 3 | 2013 | 30 | 0.900 |
Why?
|
Shoulder | 3 | 2015 | 38 | 0.890 |
Why?
|
Joint Instability | 6 | 2010 | 67 | 0.880 |
Why?
|
Lacerations | 3 | 2012 | 7 | 0.860 |
Why?
|
Video Recording | 3 | 2012 | 51 | 0.860 |
Why?
|
Treatment Outcome | 18 | 2018 | 2886 | 0.780 |
Why?
|
Postoperative Complications | 7 | 2018 | 634 | 0.750 |
Why?
|
Tissue Engineering | 6 | 2013 | 607 | 0.740 |
Why?
|
Athletic Injuries | 2 | 2010 | 72 | 0.720 |
Why?
|
Bupivacaine | 2 | 2011 | 48 | 0.720 |
Why?
|
Transplantation, Homologous | 5 | 2012 | 113 | 0.710 |
Why?
|
Patient Care | 6 | 2008 | 32 | 0.710 |
Why?
|
Tissue Scaffolds | 5 | 2016 | 385 | 0.690 |
Why?
|
Ligaments, Articular | 3 | 2009 | 38 | 0.680 |
Why?
|
Arthritis | 3 | 2013 | 37 | 0.670 |
Why?
|
Cartilage Diseases | 2 | 2009 | 20 | 0.640 |
Why?
|
Wrist Injuries | 2 | 2008 | 37 | 0.640 |
Why?
|
Patellar Ligament | 2 | 2008 | 6 | 0.640 |
Why?
|
Professional Practice | 2 | 2008 | 23 | 0.640 |
Why?
|
Tennis Elbow | 1 | 2017 | 14 | 0.620 |
Why?
|
Viscosupplements | 2 | 2013 | 2 | 0.590 |
Why?
|
Awards and Prizes | 2 | 2014 | 11 | 0.580 |
Why?
|
Hyaluronic Acid | 2 | 2013 | 44 | 0.570 |
Why?
|
Bone Screws | 3 | 2019 | 55 | 0.560 |
Why?
|
Chondrocytes | 2 | 2013 | 71 | 0.550 |
Why?
|
Patella | 4 | 2013 | 19 | 0.540 |
Why?
|
Truth Disclosure | 2 | 2011 | 12 | 0.520 |
Why?
|
Suture Techniques | 3 | 2010 | 55 | 0.500 |
Why?
|
Bibliometrics | 1 | 2014 | 6 | 0.500 |
Why?
|
Osteochondritis Dissecans | 3 | 2010 | 12 | 0.490 |
Why?
|
Industry | 3 | 2008 | 14 | 0.480 |
Why?
|
Patellofemoral Joint | 1 | 2013 | 14 | 0.470 |
Why?
|
Shoulder Dislocation | 2 | 2010 | 18 | 0.470 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2013 | 5 | 0.470 |
Why?
|
Clinical Trials as Topic | 3 | 2012 | 293 | 0.470 |
Why?
|
Internet | 2 | 2013 | 154 | 0.460 |
Why?
|
Posterior Cruciate Ligament | 1 | 2013 | 12 | 0.460 |
Why?
|
Male | 23 | 2018 | 16967 | 0.460 |
Why?
|
Health Care Costs | 2 | 2013 | 106 | 0.450 |
Why?
|
Biological Products | 1 | 2013 | 66 | 0.440 |
Why?
|
Osteoarthritis, Hip | 1 | 2012 | 15 | 0.440 |
Why?
|
Statistics as Topic | 1 | 2012 | 99 | 0.430 |
Why?
|
Knee | 1 | 2012 | 31 | 0.430 |
Why?
|
Tibia | 4 | 2014 | 56 | 0.430 |
Why?
|
Femur Head | 1 | 2012 | 12 | 0.420 |
Why?
|
Female | 23 | 2018 | 17679 | 0.420 |
Why?
|
Acetabulum | 1 | 2012 | 29 | 0.420 |
Why?
|
Humerus | 2 | 2010 | 29 | 0.410 |
Why?
|
Wrist Joint | 2 | 2008 | 47 | 0.410 |
Why?
|
United States | 10 | 2015 | 3588 | 0.410 |
Why?
|
Regeneration | 1 | 2013 | 168 | 0.410 |
Why?
|
Follow-Up Studies | 6 | 2019 | 2027 | 0.410 |
Why?
|
Therapies, Investigational | 1 | 2011 | 2 | 0.400 |
Why?
|
Osteoarthritis | 3 | 2013 | 72 | 0.400 |
Why?
|
Infusion Pumps, Implantable | 1 | 2011 | 8 | 0.400 |
Why?
|
Epiphyses, Slipped | 1 | 2010 | 4 | 0.390 |
Why?
|
Thumb | 1 | 2010 | 5 | 0.390 |
Why?
|
Technology | 1 | 2010 | 8 | 0.390 |
Why?
|
Range of Motion, Articular | 7 | 2016 | 176 | 0.380 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 202 | 0.380 |
Why?
|
Information Dissemination | 1 | 2010 | 39 | 0.380 |
Why?
|
Anesthetics, Local | 1 | 2011 | 75 | 0.370 |
Why?
|
Delivery of Health Care | 2 | 2011 | 140 | 0.370 |
Why?
|
Ethics, Medical | 1 | 2009 | 16 | 0.370 |
Why?
|
Societies, Medical | 2 | 2010 | 146 | 0.370 |
Why?
|
Mesenchymal Stem Cells | 1 | 2011 | 161 | 0.360 |
Why?
|
Audiovisual Aids | 1 | 2009 | 3 | 0.360 |
Why?
|
Arthritis, Infectious | 1 | 2009 | 21 | 0.350 |
Why?
|
History, 21st Century | 3 | 2015 | 42 | 0.350 |
Why?
|
Acromioclavicular Joint | 1 | 2009 | 8 | 0.340 |
Why?
|
Health Services Research | 1 | 2009 | 73 | 0.340 |
Why?
|
Aged | 14 | 2018 | 9256 | 0.340 |
Why?
|
Adult | 12 | 2018 | 8243 | 0.330 |
Why?
|
Decompression, Surgical | 1 | 2009 | 43 | 0.330 |
Why?
|
Methicillin Resistance | 1 | 2008 | 13 | 0.330 |
Why?
|
Hip Injuries | 1 | 2008 | 9 | 0.330 |
Why?
|
Humeral Fractures | 1 | 2008 | 33 | 0.330 |
Why?
|
Middle Aged | 16 | 2018 | 10678 | 0.320 |
Why?
|
Health Care Sector | 4 | 2008 | 18 | 0.320 |
Why?
|
Staphylococcus aureus | 1 | 2008 | 45 | 0.320 |
Why?
|
Posture | 1 | 2008 | 48 | 0.320 |
Why?
|
Death | 1 | 2008 | 40 | 0.320 |
Why?
|
Physician-Patient Relations | 6 | 2008 | 169 | 0.320 |
Why?
|
Radiography | 5 | 2018 | 339 | 0.320 |
Why?
|
Elbow | 2 | 2018 | 24 | 0.320 |
Why?
|
Staphylococcal Infections | 1 | 2008 | 57 | 0.320 |
Why?
|
Obesity | 1 | 2015 | 1079 | 0.310 |
Why?
|
Cryopreservation | 1 | 2007 | 42 | 0.310 |
Why?
|
Health Services Accessibility | 1 | 2009 | 226 | 0.310 |
Why?
|
Antibiotic Prophylaxis | 1 | 2007 | 29 | 0.300 |
Why?
|
Catheter Ablation | 1 | 2007 | 62 | 0.300 |
Why?
|
Selection Bias | 1 | 2006 | 11 | 0.300 |
Why?
|
Transplantation, Autologous | 4 | 2009 | 75 | 0.290 |
Why?
|
Prospective Studies | 5 | 2022 | 1932 | 0.290 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2006 | 48 | 0.280 |
Why?
|
Retrospective Studies | 6 | 2018 | 2930 | 0.270 |
Why?
|
Absorbable Implants | 2 | 2019 | 21 | 0.250 |
Why?
|
Pain Measurement | 3 | 2015 | 328 | 0.250 |
Why?
|
Shoulder Impingement Syndrome | 2 | 2013 | 9 | 0.230 |
Why?
|
Stroke | 1 | 2008 | 443 | 0.230 |
Why?
|
Knee Prosthesis | 3 | 2016 | 14 | 0.230 |
Why?
|
History, 20th Century | 2 | 2015 | 63 | 0.220 |
Why?
|
Adipose Tissue | 2 | 2015 | 337 | 0.220 |
Why?
|
Femur | 3 | 2014 | 67 | 0.220 |
Why?
|
Magnetic Resonance Imaging | 4 | 2015 | 1144 | 0.220 |
Why?
|
Reoperation | 3 | 2016 | 196 | 0.220 |
Why?
|
Comparative Effectiveness Research | 2 | 2013 | 23 | 0.210 |
Why?
|
Forecasting | 2 | 2013 | 130 | 0.210 |
Why?
|
Rupture | 2 | 2013 | 29 | 0.210 |
Why?
|
Cost-Benefit Analysis | 2 | 2013 | 152 | 0.200 |
Why?
|
Tensile Strength | 4 | 2016 | 52 | 0.200 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2013 | 75 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 4 | 2014 | 858 | 0.190 |
Why?
|
Comorbidity | 2 | 2015 | 531 | 0.190 |
Why?
|
Equipment Design | 3 | 2014 | 161 | 0.180 |
Why?
|
Interprofessional Relations | 3 | 2008 | 47 | 0.180 |
Why?
|
Deja Vu | 1 | 2019 | 1 | 0.180 |
Why?
|
Age Factors | 2 | 2012 | 1058 | 0.170 |
Why?
|
Time Factors | 3 | 2018 | 1874 | 0.170 |
Why?
|
Internship and Residency | 1 | 2022 | 264 | 0.160 |
Why?
|
Ethics, Clinical | 2 | 2008 | 6 | 0.160 |
Why?
|
Professional Competence | 2 | 2008 | 16 | 0.160 |
Why?
|
Activities of Daily Living | 2 | 2016 | 216 | 0.160 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 36 | 0.160 |
Why?
|
Computer Simulation | 1 | 2018 | 187 | 0.160 |
Why?
|
Rotation | 2 | 2016 | 44 | 0.150 |
Why?
|
Upper Extremity | 1 | 2017 | 48 | 0.150 |
Why?
|
Muscle Strength | 1 | 2017 | 123 | 0.150 |
Why?
|
Pain, Postoperative | 3 | 2013 | 167 | 0.150 |
Why?
|
Cadaver | 2 | 2007 | 143 | 0.150 |
Why?
|
Injections, Intra-Articular | 2 | 2023 | 11 | 0.140 |
Why?
|
Adolescent | 4 | 2018 | 3184 | 0.140 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 521 | 0.140 |
Why?
|
Mechanical Phenomena | 1 | 2016 | 27 | 0.140 |
Why?
|
Portraits as Topic | 1 | 2015 | 4 | 0.140 |
Why?
|
Ulnar Neuropathies | 1 | 2015 | 16 | 0.140 |
Why?
|
Muscular Atrophy | 1 | 2015 | 67 | 0.130 |
Why?
|
Neuromuscular Junction | 1 | 2015 | 61 | 0.130 |
Why?
|
Authorship | 2 | 2011 | 8 | 0.130 |
Why?
|
Postoperative Period | 1 | 2015 | 89 | 0.130 |
Why?
|
Incidence | 2 | 2008 | 1087 | 0.130 |
Why?
|
Research Support as Topic | 2 | 2011 | 25 | 0.130 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2015 | 59 | 0.130 |
Why?
|
Health Surveys | 1 | 2015 | 189 | 0.130 |
Why?
|
Case-Control Studies | 2 | 2015 | 886 | 0.130 |
Why?
|
PubMed | 1 | 2013 | 4 | 0.120 |
Why?
|
Ultrasonography | 2 | 2015 | 347 | 0.120 |
Why?
|
Consensus | 1 | 2013 | 66 | 0.120 |
Why?
|
Ambulatory Care Facilities | 1 | 2013 | 62 | 0.120 |
Why?
|
Health Expenditures | 1 | 2013 | 60 | 0.120 |
Why?
|
Biocompatible Materials | 2 | 2012 | 209 | 0.120 |
Why?
|
Ligaments | 2 | 2016 | 12 | 0.120 |
Why?
|
Treatment Failure | 1 | 2013 | 142 | 0.120 |
Why?
|
Peer Review | 1 | 2012 | 6 | 0.110 |
Why?
|
Reproducibility of Results | 2 | 2012 | 700 | 0.110 |
Why?
|
Freeze Drying | 1 | 2012 | 2 | 0.110 |
Why?
|
Bioreactors | 1 | 2013 | 59 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2007 | 441 | 0.110 |
Why?
|
Software | 1 | 2013 | 106 | 0.110 |
Why?
|
Animals | 4 | 2016 | 6402 | 0.110 |
Why?
|
Disability Evaluation | 1 | 2013 | 202 | 0.110 |
Why?
|
Meta-Analysis as Topic | 2 | 2011 | 42 | 0.110 |
Why?
|
RNA | 1 | 2012 | 83 | 0.110 |
Why?
|
North Carolina | 3 | 2018 | 1412 | 0.100 |
Why?
|
Efficiency | 1 | 2011 | 14 | 0.100 |
Why?
|
Fees and Charges | 1 | 2011 | 14 | 0.100 |
Why?
|
Aged, 80 and over | 2 | 2018 | 3562 | 0.100 |
Why?
|
India | 1 | 2011 | 62 | 0.100 |
Why?
|
Intraoperative Care | 1 | 2011 | 48 | 0.100 |
Why?
|
RNA, Messenger | 1 | 2013 | 498 | 0.100 |
Why?
|
Biomedical Technology | 1 | 2011 | 6 | 0.100 |
Why?
|
Writing | 2 | 2011 | 10 | 0.100 |
Why?
|
DNA | 1 | 2012 | 207 | 0.100 |
Why?
|
Basketball | 1 | 2010 | 5 | 0.100 |
Why?
|
Thinking | 1 | 2010 | 6 | 0.100 |
Why?
|
Femur Neck | 1 | 2010 | 20 | 0.100 |
Why?
|
Debridement | 1 | 2010 | 42 | 0.100 |
Why?
|
Information Seeking Behavior | 1 | 2010 | 6 | 0.100 |
Why?
|
Surgery, Computer-Assisted | 1 | 2011 | 50 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2011 | 66 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 1 | 2011 | 72 | 0.100 |
Why?
|
Decision Making | 1 | 2012 | 154 | 0.100 |
Why?
|
China | 1 | 2010 | 42 | 0.090 |
Why?
|
Models, Theoretical | 1 | 2011 | 119 | 0.090 |
Why?
|
Editorial Policies | 1 | 2009 | 13 | 0.090 |
Why?
|
Financing, Government | 1 | 2009 | 10 | 0.090 |
Why?
|
Spain | 1 | 2008 | 3 | 0.090 |
Why?
|
Bone and Bones | 2 | 2009 | 88 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2009 | 45 | 0.090 |
Why?
|
Cohort Studies | 3 | 2015 | 1673 | 0.090 |
Why?
|
Adjuvants, Anesthesia | 1 | 2008 | 5 | 0.090 |
Why?
|
Language | 1 | 2008 | 43 | 0.080 |
Why?
|
New Mexico | 1 | 2008 | 5 | 0.080 |
Why?
|
Bone Diseases | 1 | 2008 | 16 | 0.080 |
Why?
|
Arthralgia | 1 | 2008 | 30 | 0.080 |
Why?
|
Ethical Review | 1 | 2008 | 2 | 0.080 |
Why?
|
Biological Science Disciplines | 1 | 2008 | 2 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2008 | 58 | 0.080 |
Why?
|
Carbon Compounds, Inorganic | 1 | 2008 | 1 | 0.080 |
Why?
|
Bone Cysts | 1 | 2008 | 4 | 0.080 |
Why?
|
Ethics Committees, Research | 1 | 2008 | 18 | 0.080 |
Why?
|
Professional Misconduct | 1 | 2008 | 3 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2008 | 60 | 0.080 |
Why?
|
Human Experimentation | 1 | 2008 | 17 | 0.080 |
Why?
|
Seasons | 1 | 2008 | 81 | 0.080 |
Why?
|
Community-Acquired Infections | 1 | 2008 | 32 | 0.080 |
Why?
|
Granuloma | 1 | 2008 | 13 | 0.080 |
Why?
|
Professional Role | 1 | 2008 | 19 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2008 | 54 | 0.080 |
Why?
|
Lactic Acid | 1 | 2008 | 50 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2008 | 51 | 0.080 |
Why?
|
Polymers | 1 | 2008 | 56 | 0.080 |
Why?
|
Polyesters | 1 | 2008 | 70 | 0.080 |
Why?
|
Collagen | 1 | 2009 | 221 | 0.080 |
Why?
|
Ankle | 1 | 2007 | 20 | 0.080 |
Why?
|
Blood Pressure Determination | 1 | 2008 | 92 | 0.080 |
Why?
|
Foot | 1 | 2007 | 38 | 0.080 |
Why?
|
Endoscopy | 1 | 2007 | 38 | 0.080 |
Why?
|
Sheep | 1 | 2008 | 218 | 0.080 |
Why?
|
Bone Transplantation | 1 | 2007 | 46 | 0.080 |
Why?
|
Guided Tissue Regeneration | 1 | 2007 | 36 | 0.080 |
Why?
|
Surgical Stapling | 1 | 2006 | 11 | 0.070 |
Why?
|
Cells, Cultured | 1 | 2009 | 779 | 0.070 |
Why?
|
Weight-Bearing | 1 | 2006 | 40 | 0.070 |
Why?
|
Stress, Mechanical | 1 | 2006 | 89 | 0.070 |
Why?
|
Hip Fractures | 1 | 2006 | 27 | 0.070 |
Why?
|
Economics, Hospital | 1 | 2005 | 6 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2007 | 225 | 0.070 |
Why?
|
Atrophy | 1 | 2005 | 51 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2006 | 67 | 0.070 |
Why?
|
Clinical Competence | 3 | 2018 | 296 | 0.070 |
Why?
|
Costs and Cost Analysis | 1 | 2005 | 84 | 0.070 |
Why?
|
Osseointegration | 1 | 2004 | 1 | 0.060 |
Why?
|
Inflammation | 1 | 2008 | 501 | 0.060 |
Why?
|
Fluoroscopy | 1 | 2004 | 37 | 0.060 |
Why?
|
Fracture Fixation | 1 | 2004 | 35 | 0.060 |
Why?
|
Occupational Diseases | 1 | 2004 | 78 | 0.060 |
Why?
|
Synovial Fluid | 1 | 2023 | 7 | 0.060 |
Why?
|
Radius Fractures | 1 | 2004 | 53 | 0.060 |
Why?
|
Placebo Effect | 1 | 2002 | 14 | 0.060 |
Why?
|
Wound Healing | 1 | 2023 | 180 | 0.050 |
Why?
|
Pilot Projects | 1 | 2002 | 437 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 113 | 0.050 |
Why?
|
Tourniquets | 1 | 2018 | 11 | 0.040 |
Why?
|
Young Adult | 2 | 2018 | 2321 | 0.040 |
Why?
|
Guideline Adherence | 2 | 2008 | 110 | 0.040 |
Why?
|
alpha-Galactosidase | 1 | 2016 | 3 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2018 | 184 | 0.040 |
Why?
|
Swine | 1 | 2016 | 198 | 0.040 |
Why?
|
Movement | 1 | 2016 | 32 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2016 | 251 | 0.030 |
Why?
|
Electrodiagnosis | 1 | 2015 | 34 | 0.030 |
Why?
|
Risk | 1 | 2016 | 290 | 0.030 |
Why?
|
Body Mass Index | 1 | 2018 | 890 | 0.030 |
Why?
|
Patellofemoral Pain Syndrome | 1 | 2013 | 2 | 0.030 |
Why?
|
Child | 1 | 2018 | 2151 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2011 | 21 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 1345 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 89 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 486 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 95 | 0.020 |
Why?
|
Risk Factors | 1 | 2018 | 3520 | 0.020 |
Why?
|
Proprioception | 1 | 2009 | 4 | 0.020 |
Why?
|
Survival Analysis | 1 | 2011 | 424 | 0.020 |
Why?
|
Quality of Life | 1 | 2015 | 792 | 0.020 |
Why?
|
Ethics, Institutional | 1 | 2008 | 1 | 0.020 |
Why?
|
Codes of Ethics | 1 | 2008 | 2 | 0.020 |
Why?
|
Ethics, Professional | 1 | 2008 | 5 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 2008 | 20 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2008 | 43 | 0.020 |
Why?
|
Cell-Free System | 1 | 2007 | 15 | 0.020 |
Why?
|
Materials Testing | 1 | 2007 | 83 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2006 | 11 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2006 | 134 | 0.020 |
Why?
|
Exercise | 1 | 2009 | 567 | 0.020 |
Why?
|
Fractures, Comminuted | 1 | 2004 | 8 | 0.020 |
Why?
|
Hand Strength | 1 | 2004 | 82 | 0.020 |
Why?
|
Mice | 1 | 2007 | 2181 | 0.010 |
Why?
|